These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 3879464)
21. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Phillips I; Warren C; Shannon K; King A; Hanslo D J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance. Del Bene VE; Carek PJ; Twitty JA; Burkey LJ Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165. Neu HC; Chin NX Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528 [TBL] [Abstract][Full Text] [Related]
24. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin. Toda M; Arao N; Nohara C; Susaki K; Tachibana A Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of a new cephalosporin ME-1206 compared with other agents. Chin NX; Zhang YX; Neu HC Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456 [TBL] [Abstract][Full Text] [Related]
26. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks. Jones RN; Barry AL; Thornsberry C Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093 [TBL] [Abstract][Full Text] [Related]
27. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Neu HC; Chin NX; Saha G; Labthavikul P Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin). Bauernfeind A; Schweighart S; Eberlein E; Jungwirth R Infection; 1991; 19 Suppl 5():S264-75. PubMed ID: 1664418 [TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin. Neu HC; Chin NX; Labthavikul P Antimicrob Agents Chemother; 1984 Aug; 26(2):174-80. PubMed ID: 6333207 [TBL] [Abstract][Full Text] [Related]
30. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375 [TBL] [Abstract][Full Text] [Related]
31. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
32. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli. Dabernat HJ; Delmas C Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Neu HC; Chin NX; Labthavikul P Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827 [TBL] [Abstract][Full Text] [Related]
35. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]. Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics. Perrymann F; Flournoy DJ; Qadri SM Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865 [TBL] [Abstract][Full Text] [Related]
37. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin. Neu HC; Chin NX; Huang HB Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925 [TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Fu KP; Neu HC Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294 [TBL] [Abstract][Full Text] [Related]
39. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of cefbuperazone against anaerobic bacteria. Wexler H; Carter WT; Harris BH; Finegold SM Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]